Special issue: Drug metabolism and psychiatry: Part I of II - Preface

被引：0
作者：
Baker, GB
机构：
来源：
CELLULAR AND MOLECULAR NEUROBIOLOGY | 1999年 / 19卷 / 03期
关键词：
D O I：
10.1023/A:1006206814025
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
引用
收藏
页码：301 / 308
页数：8
相关论文
共 39 条
[1]   PREVALENCE OF CYP2D6 GENE DUPLICATION AND ITS REPERCUSSION ON THE OXIDATIVE PHENOTYPE IN A WHITE-POPULATION [J].
AGUNDEZ, JAG ;
LEDESMA, MC ;
LADERO, JM ;
BENITEZ, J .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1995, 57 (03) :265-269
[2]   Use of in vitro and in vivo data to estimate the likelihood of metabolic pharmacokinetic interactions [J].
Bertz, RJ ;
Granneman, GR .
CLINICAL PHARMACOKINETICS, 1997, 32 (03) :210-258
[3]   Importance of stereospecific bioanalytical monitoring in drug development [J].
Caldwell, J .
JOURNAL OF CHROMATOGRAPHY A, 1996, 719 (01) :3-13
[4]   The cytochrome P450 2D6 (CYP2D6) enzyme polymorphism: Screening costs and influence on clinical outcomes in psychiatry [J].
Chen, SQ ;
Chou, WH ;
Blouin, RA ;
Mao, ZP ;
Humphries, LL ;
Meek, C ;
Neill, JR ;
Martin, WL ;
Hays, LR ;
Wedlund, PJ .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1996, 60 (05) :522-534
[5]  
Ciraulo DA, 1995, DRUG INTERACTIONS PS
[6]   IMPLICATIONS OF CHIRALITY AND GEOMETRIC ISOMERISM IN SOME PSYCHOACTIVE-DRUGS AND THEIR METABOLITES [J].
COUTTS, RT ;
BAKER, GB .
CHIRALITY, 1989, 1 (02) :99-120
[7]  
COUTTS RT, 1994, J PSYCHIATR NEUROSCI, V19, P30
[8]   GENETIC-ANALYSIS OF THE CYP2D LOCUS IN RELATION TO DEBRISOQUINE HYDROXYLATION CAPACITY IN KOREAN, JAPANESE AND CHINESE SUBJECTS [J].
DAHL, ML ;
YUE, QY ;
ROH, HK ;
JOHANSSON, I ;
SAWE, J ;
SJOQVIST, F ;
BERTILSSON, L .
PHARMACOGENETICS, 1995, 5 (03) :159-164
[9]  
DEVANE CL, 1994, J CLIN PSYCHIAT, V55, P38
[10]  
GIBSON GG, 1994, INTRO DRUG METABOLIS
1234